Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 15, 2020

SELL
$26.15 - $77.24 $75,181 - $222,064
-2,875 Closed
0 $0
Q4 2019

Jan 14, 2020

SELL
$60.18 - $154.77 $2.83 Million - $7.27 Million
-46,990 Reduced 94.23%
2,875 $208,000
Q3 2019

Oct 31, 2019

SELL
$140.29 - $189.96 $1.67 Million - $2.26 Million
-11,880 Reduced 19.24%
49,865 $7 Million
Q2 2019

Jul 31, 2019

SELL
$157.85 - $183.09 $123,123 - $142,810
-780 Reduced 1.25%
61,745 $11.3 Million
Q1 2019

Apr 30, 2019

SELL
$89.33 - $163.65 $1.73 Million - $3.17 Million
-19,360 Reduced 23.64%
62,525 $9.95 Million
Q4 2018

Feb 08, 2019

SELL
$81.94 - $139.71 $374,056 - $637,776
-4,565 Reduced 5.28%
81,885 $7.84 Million
Q3 2018

Nov 13, 2018

SELL
$138.11 - $169.04 $1.5 Million - $1.83 Million
-10,845 Reduced 11.15%
86,450 $12.2 Million
Q2 2018

Aug 13, 2018

BUY
$140.36 - $175.76 $5.75 Million - $7.2 Million
40,940 Added 72.65%
97,295 $15.2 Million
Q1 2018

May 14, 2018

BUY
$152.15 - $192.33 $2.9 Million - $3.66 Million
19,055 Added 51.09%
56,355 $9.08 Million
Q4 2017

Feb 13, 2018

SELL
$60.72 - $167.34 $1.31 Million - $3.61 Million
-21,600 Reduced 36.67%
37,300 $6.14 Million
Q3 2017

Oct 30, 2017

BUY
$61.4 - $88.52 $3.62 Million - $5.21 Million
58,900
58,900 $3.67 Million

Others Institutions Holding SAGE

About Sage Therapeutics, Inc.


  • Ticker SAGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,422,300
  • Market Cap $340M
  • Description
  • Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...
More about SAGE
Track This Portfolio

Track Tocqueville Asset Management L.P. Portfolio

Follow Tocqueville Asset Management L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tocqueville Asset Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Tocqueville Asset Management L.P. with notifications on news.